Mechanistically, MBD2 selectively bound to the methylated CpG DNA within the damage-specific DNA binding protein 2 (DDB2) promoter, by which it repressed DDB2 expression to enhance EMT process, thereby leading to tumor metastasis. The gene discussed is DDB2; the disease is neoplasm.